Our Leaders

Mark Thierer is a lifelong leader in the healthcare space with more than 30 years of experience leading organizations to financial and operational success in the healthcare system. As Chief Executive Officer, he leads EVERSANA’s vision to accelerate the industry’s shift to patient-centered, value-based care – creating a healthier world for all. He is also the founder of Waltz Health with his son, Jonathon Thierer, which merged with EVERSANA in August 2025.

Most recently Mark served as CEO of OptumRx, overseeing all Optum pharmacy care services, including the management of pharmacy benefits, pharmacy network, homedelivery pharmacy and specialty pharmacy programs. Prior to OptumRx, Mark served as the Chairman of the Board and CEO of Catamaran (NASDAQ: CTRX), one of the nation’s largest pharmacy benefit management companies serving 35 million lives. Catamaran was acquired by United Healthcare in 2015 and combined with OptumRx. Earlier in his career, Mark served as President, CEO and Chairman of SXC Health Solutions, which merged with Catalyst Health Solutions to create Catamaran. During his time as CEO of SXC Health Solutions, the company posted a compound annual growth rate of 50 percent and had a 50-fold increase in shareholder value. Prior to this, Mark led Physicians Interactive, a division of Allscripts Healthcare Solutions, Inc., as President. He spent 10 years with CaremarkRx (now CVS Caremark) as a Corporate Officer and Senior Vice President, Industry Relations. Before joining Caremark, he spent 10 years at IBM in various sales management positions in its health industry division.

Mark holds a Bachelor of Science degree in Finance from the University of Minnesota, a Master’s in Business Administration from Nova Southeastern University and has earned the Certified Employee Benefits Specialist (CEBS) designation.

Gregory is responsible for accelerating the company’s growth and ensuring the success of all client commercialization efforts. With more than 25 years of executive leadership, Gregory understands all facets of the pharmaceutical industry, spanning clinical operations to commercial success. Gregory’s previous roles include Chief Enterprise Business Officer and Executive Vice President and General Manager at a global bio-pharmaceutical solutions organization, where he successfully managed business units and teams of several thousand employees. Skalicky holds a Bachelor of Science in Biology from Temple University and a Master of Business Administration from Villanova University. He is an active member across several industry panels and consortiums.

Jeff helps payers and life sciences partners improve access, affordability, and patient outcomes. An experienced leader in driving growth and meaningful change in healthcare, Jeff’s early career in the venture capital sector has helped shape his focus on leveraging technology and innovation to drive growth and make positive change. He’s a seasoned leader in healthcare, technology, and innovation whose career includes senior executive positions at many industry leaders. Formerly the Chairman and CEO of independent pharmacy benefit manager (PBM) WellDyneRx, Park’s background gives him some of the deepest knowledge and connections within the prescription drug supply chain. He also previously served as the Chief Operating Officer of PBM industry titan OptumRx.

Kelly directs the company’s financial excellence and leads the platform’s investment and growth strategies. With more than 15 years of financial leadership experience in the healthcare sector, Kelly is a highly regarded financial leader with extensive experience in high-growth organizations, leading mergers and acquisitions. Kelly is a graduate of Union College and earned a Master’s Degree from New York University.

Faruk is EVERSANA’s Chief Innovation Officer and the Chief Executive Officer of EVERSANA INTOUCH, the best-in-class full-service marketing and creative agency of more than 1,800 employees globally that joined EVERSANA in December 2021. Faruk leads the agency team to drive next-generation ideas and strategies for clients across the pharmaceutical and life science industries. He is a graduate of Marmara University and holds a Master of Business Administration from the University of Central Missouri.

Mark leads EVERSANA’s Information Technology systems and strategies. He brings more than 30 years of healthcare and Prescription Benefit Management business experience to the company, including executive roles at Medco, OptumRx, Zelis Healthcare, United Healthcare, and most recently, Waltz Health. His prior leadership roles and responsibilities have included driving technology transformation and leading the adoption of advanced technologies as required to support both clients and their membership.

Fred is the Chief Human Resources Officer at EVERSANA and leads the company’s effort to build a thriving culture and earn recognition as a best place to work. With nearly 20 years of experience in the HR industry, Skinner brings a wide array of experience across employee engagement and talent acquisition functions from multiple industries, including consulting, healthcare, software development, diversified manufacturing and automotive.   He holds a Master’s Degree from Roosevelt University.

Monica leads EVERSANA’s Legal and Compliance function. She has more than two decades of experience as a senior legal executive and business leader across top law firms and global companies, including UnitedHealth Group and Elevance Health. Monica brings a proven record of legal leadership through periods of growth, complexity, and transformation, with deep expertise at the intersection of healthcare, law and emerging technologies. Throughout her career, Monica has built high-performing, financially disciplined legal teams, advised executive leadership and boards on enterprise strategy, and guided businesses through complex regulatory and operational landscapes. As Chief Legal Officer, Monica provides strategic leadership that integrates governance, risk, compliance, and operational execution, enabling innovation, supporting enterprise objectives, and driving long-term value. Monica holds a BA in Biology from the University of Missouri-Kansas City and a Juris Doctor from Suffolk University Law School.

Dr. Russo serves as EVERSANA’s Chief Medical Officer.  He is responsible for ensuring the highest levels of quality and data integrity in the design and delivery of projects that require the translation of clinical, population medicine and health economic knowledge into actionable analyses across all programs. A cardiac thoracic and transplant surgeon, he began his career at the Mayo Clinic, and then served in clinical leadership roles at several academic hospitals including Temple University/St Christopher’s Hospital, Philadelphia and the University of Missouri. He holds a Certificate in Health Care Innovation-Health and Health Care Administration Management from the University of Pennsylvania-Philadelphia and a Certificate in Digital Medicine (Node.Health).  He is a member of the American Heart Association and has served as a lecturer in population medicine at the Harvard Medical School.

Brian oversees EVERSANA’s growing Patient Services team, where he leads efforts to simplify care, improve access, and lower costs by delivering innovative, patient-centered therapy access solutions. With over 25 years of experience across pharmacy operations, clinical services, product development, and marketing, he brings a deep commitment to innovation and growth. Beginning his career as a pharmacist in ambulatory care, Brian’s patient-first approach continues to shape his strategic leadership. He has held executive roles at OptumRx and HealthDyne, where he drove specialty pharmacy expansion and tech-enabled patient service delivery. Brian holds a Pharmacy Degree from the University of Mississippi School of Pharmacy and a Masters Degree in Pharmacy Outcomes and Policy from the University of Florida.

Drew spearheads the organization’s data strategy and organizational philosophy regarding data-driven insights across services and solutions. He also in early 2026 assumed the role of Chief Operating Officer for the company’s agency division, EVERSANA INTOUCH.  With more than a decade of experience, including investing and operating in Healthcare Information technology and Digital Life Sciences industries, he brings a unique perspective on innovative technologies and disruptive delivery models, with an ever-present goal to drive actionable and quantifiable impact. Drew completed his undergraduate and master’s degree from the University of Texas at Austin. 

Angela leads EVERSANA global agency network, which includes six full-service agencies and four specialty agencies. With over 25 years of marketing experience in the healthcare vertical at EVERSANA INTOUCH, she has led the industry and the agency’s clients through many firsts.  She has a proven track record of building integrated teams, pushing for novel approaches, and stopping at nothing to deliver great work. Angela has been recognized as Healthcare Businesswomen’s Association Luminary, an MM+M Pinnacle award honoree, and a PM360 Elite 100 recipient.  She’s a board member with the American Association of Advertising Agencies and the Coalition for Healthcare Communications.

With more than 25 years of experience in the pharmaceutical industry, Krista leads EVERSANA’s Deployment Solutions service line. Propelled with power of data, analytics and digital technology, Krista is transforming the strategy, activation and impact of field-based commercial, medical and market access teams to drive stronger program performance for therapies worldwide. Recently recognized as a MM&M Hall of Femme Honoree and a two-time Rising Star by the Healthcare Businesswoman’s Association, Krista holds a Bachelor’s Degree from the University of Delaware.

Danny leads EVERSANA’s Channel Management service line. He brings more than 20 years of experience leading teams to excel in commercial aspects of the pharmaceutical and services industries.  His team helps to efficiently deliver therapies to patients, ensure regulatory compliance, and support medical information and pharmacovigilance.  Danny is a graduate of the University of Mississippi, and holds a Master of Business Administration from Mississippi College.

Vikram leads EVERSANA’s Compliance Service service line. His experiences include more than 20 years of leading global teams and building successful partnerships with top life sciences companies and health authorities around the globe. His team includes Medical Communications, Pharmacovigilance, Product and Medical Information Contact Center, and Regulatory & Quality Consulting/Outsourcing Services. He holds a Bachelor in Science Degree in Pharmacy from Punjabi University, a Master of Business Administration from Manipal University, and Post Graduate Diploma in Digital Strategies & Transformation from Columbia Business School/MIT Sloan.

Faruk leads EVERSANA’s Professional Services Division including multiple advisory teams as well as the value & evidence service line.  He is responsible for driving growth and accelerating go-to-market efforts for EVERSANA.  His career spans more than 20 years in corporate strategy and business development, customer engagement, entrepreneurship and technology. Most recently in EVERSANA, he led the growth and expansion of the EVERSANA CONSULTING team across the North American and European regions. Prior to joining EVERSANA, he was a senior leader at various consulting firms and technology companies, helping contribute to the successful development and launch of products across therapeutic and medical device categories. He holds a Bachelor’s Degree in Electrical Engineering from Northwestern University and a Master of Business Administration from Harvard Business School.

Alan drives the US and Global pricing and access product portfolio at EVERSANA, an industry-leading group of products covering brand, global pricing and market access data, and revenue software. Alan leads this team in helping EVERSANA address clients’ global product lifecycle and price and access needs. With more than 20 years in the life sciences industry, his experience includes spearheading innovative software, data and solutions for global pricing and access, global data collection and analysis, and leveraging advanced algorithms to support commercial decisions. He has shared his expertise globally at industry conferences and has led numerous large-scale technology projects throughout his career. Alan worked previously as a vice president at CapGemini and at Accenture. Alan is a graduate of Princeton University.

Jim Burke leads the Revenue Management team with more than 20 years of experience optimizing gross-to-net operations for the pharmaceutical and medical device industries. An established thought leader in life sciences, he drives the implementation of best practices and innovative solutions that help companies optimize their investment in access and affordability programs through a combination of process efficiencies and holistic life cycle analytics. His team leads the way in creating first-to-market software programs that eliminate revenue leakage through unique automated transaction validation algorithms and master data alignment. Jim is an alumnus of the Stevens Institute of Technology. 

Mike leads EVERSANA’s operations in Europe, the Middle East and Africa, and is responsible for accelerating growth throughout the region. He brings more than 25 years of experience to the industry, having held global leadership positions in both clinical development and life sciences software companies. Ryan passionately believes that technology can simplify the development of novel therapies and improve access to treatment. He holds a degree in Industrial Biochemistry from University Limerick and earned his Master of Business Administration from the University College Cork.

Roberto is a pioneer in digital health and a recognized thought leader, people-inspiring founder and serial entrepreneur. Trained as a medical doctor with a degree in marketing and communications, his passion for medicine, computer science and human-technology interactions have led to his lifelong commitment and dedication to the advancement of digital healthcare. In 1997, he founded Healthware Group, which joined EVERSANA in 2023, and is a regular keynote speaker at global events and author of the books “The Future of Health” (Wiley) and “Il Futuro della Salute” (Hoepli), Chairman at Frontiers Health, a  leading health innovation conference, and is a founding advisor to the Digital Therapeutics Alliance (DTA). Roberto holds degrees from the University S. Orsola Benincasa in Naples, Italy, and is active in the health innovation ecosystem in various advisor capacities both across Europe and the United States.